Accelerating the development of affordable new vaccines for the developing world is one of the most important factors in reducing child deaths and lifting the burden of disease that afflicts many poor countries. Even as global child deaths have declined from 12.6 million to 6.6 million over the last two decades, preventable diseases like pneumonia, diarrheal disease and malaria remain the world’s leading causes of death among children under age 5.
That’s why I was particularly pleased to participate in an announcement today at the annual Grand Challenges Meeting in Brazil about a new initiative that will lead to better and more effective approaches to vaccine research and development.
This new effort – known as the Vaccine Discovery Partnership – will be a way for our foundation to work directly with pharmaceutical companies on promising new vaccines for global health.
Read the rest of the post here.